Screening Examination of Premature Infants for Retinopathy of Prematurity

Pediatrics
|November 28, 2018
PubMed

Insights

This policy statement updates guidelines for screening preterm infants for retinopathy of prematurity (ROP). Early detection and timely treatment of ROP are crucial to prevent vision loss and blindness in at-risk infants.

Area of Science:

  • Ophthalmology
  • Neonatology
  • Public Health

Background:

  • Retinopathy of prematurity (ROP) is a serious eye condition affecting preterm infants.
  • Untreated ROP can lead to retinal detachment, visual impairment, or blindness.
  • Effective treatment for severe ROP has been available for decades, but requires timely diagnosis.

Purpose of the Study:

  • To revise and update the 2013 policy statement on ROP screening in preterm infants.
  • To outline the essential components of an effective ROP detection and treatment program.
  • To provide guidance on the optimal timing for initial and follow-up ROP examinations.

Main Methods:

  • Review and revision of existing ROP screening guidelines.
  • Emphasis on the sequential nature of ROP progression.
  • Inclusion of recommendations for timely diagnosis and treatment initiation.

Main Results:

  • Updated policy statement on ROP screening.
  • Guidelines for identifying at-risk preterm infants.
  • Recommendations for appropriate examination schedules to detect ROP changes.

Conclusions:

  • Timely diagnosis of ROP is critical for effective treatment.
  • Adherence to updated screening protocols can prevent severe visual outcomes.
  • Comprehensive ROP programs are essential for preserving vision in preterm infants.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
295
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.7K
Urologic Endoscopic Procedure: Cystoscopic Examination01:28

Urologic Endoscopic Procedure: Cystoscopic Examination

Meaning of Cystoscopic Examination:Cystoscopy is an essential diagnostic tool in urology that is used to assess the structure and function of the genitourinary system. It provides a direct view of the urethra, bladder, and, in some cases, the ureteral openings. This procedure helps detect structural abnormalities, infections, cancers, and blockages in the urinary tract. There are two types of cystoscopy:Flexible cystoscopy is commonly performed in outpatient settings due to its less invasive...
3.0K
Mutations01:39

Mutations

Overview
94.5K
Improving Translational Accuracy02:07

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
14.9K
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
11.8K